Interested in joining our ID-Care Team? Check out the following 3 new job opportunities.
https://www.univr.it/it/concorsi/assegnisti-di-ricerca/assegni-di-ricerca/0/10674 Selezione AdR4046/22 per il conferimento di n. 1...
Search
Antibiotico-resistenza, Italia ultima tra i Paesi industrializzati, con 11mila decessi l’anno.
I dati presentati al Convegno ACTA Reboot a Milano. Evelina Tacconelli: “I nostri studi su un uso corretto degli antibiotici dimostrano...
University of Verona to lead the update of the 2017 WHO bacterial priority pathogens list (BPPL)
In the implementation of the Global Action Plan on Antimicrobial Resistance (AMR), WHO has selected the University of Verona,...
The VACCELERATE Volunteer Clinical Trial Registry is launched in Italy
The VACCELERATE Volunteer Registry is now open in Italy. This database, developed in the context of the clinical research network...
We are hiring!
Entra a far parte del nostro Team ID-Care. Join our ID-Care Team. Qui di seguito trovate le ultime proposte di collaborazione (4) con...
New Project “BY YOUTH SIDE!
New Project “BY YOUTH SIDE! Inclusive health services for young people in the fight against HIV” launches in Kenya! The ID-CARE team of...
32nd European Congress of Clinical Microbiology & Infectious Diseases
𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝗵𝗼𝗺𝗲 𝘁𝗼 𝗼𝘂𝗿 𝗜𝗗-𝗖𝗮𝗿𝗲 𝗧𝗲𝗮𝗺 𝘄𝗵𝗼 𝗵𝗮𝘀 𝗷𝘂𝘀𝘁 𝗿𝗲𝘁𝘂𝗿𝗻𝗲𝗱 𝗳𝗿𝗼𝗺 𝗟𝗶𝘀𝗯𝗼𝗻 𝗮𝗳𝘁𝗲𝗿...
IDCARE TEAM LAND AT ECCMID 2022
𝗦𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗺𝗲𝗺𝗯𝗲𝗿𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗜𝗗𝗖𝗮𝗿𝗲 𝗧𝗲𝗮𝗺 𝘄𝗶𝗹𝗹 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁 𝘁𝗵𝗲 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗼𝗳...
First hospital in Italy to administer the Monoclonal Antibody to fragile patients affected by COVID-
The first symptomatic, immunosuppressed patient aged 55 with SARS-CoV-2 infection with the Monoclonal Antibody (Evusheld) was treated at...
Clinical Study at the centre of the REVERSE project officially kicked off
The kick-off meeting with the 24 participating hospitals( in Greece, Italy, Romania and Spain) and the project consortium on 23 February...
Launch of New Foundation: Ecraid
Verona University is member of this new European Clinical Resarch Alliance for Infectious Diseases Ecraid begins its fight against...
PRIMAVERA (PRedicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial ResistAnce):
A NEW OPEN SOURCE PLATFORM FOR THE STUDY OF MONOCLONAL ANTIBODIES AND VACCINES ON ANTIMICROBIAL RESISTANCE A 5-year project, funded by...
ORCHESTRA mentioned in the national news
ORCHESTRA mentioned in the national news as Prof. Evelina Tacconelli highlights how the project has been studying the long term sequels...
3rd of December 2021 - Annual EPI-Net meeting and One-Health Consensus Report
Today the annual EPI-Net meeting takes place virtually with the participation of 53 experts from multidisciplinary backgrounds from...
PrIMAVeRa in Full Bloom
PrIMAVeRa is a new European project funded by the Innovative Medicines Initiative 2 (IMI2) with the goal of developing an open-source,...
Fighting Antibiotic Resistance: AIFA-OPERA Task Force
Italy ranks high in terms of prevalence of multidrug resistant germs among European countries. On the ‘European Antibiotic Awareness...
VERDI Project Launch
Padova, Italy – 15 November 2021 Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus...
MISTRA - a Multidisciplinary Approach to Sexually Transmitted Infections
Within ID CARE, MISTRA is our clinic focused on the prevention, early detection and management of HIV and other Sexually Transmitted...
VACCELERATE Italy - We Are Growing!
Even more sites all over the country, have joined the EUVAP (European Vaccine Trial Platform). They are now part of a Europe-wide...